Abstract
Synthesis and biological assessment of triazolo-quinazoline carbothioamide derivatives for p38 MAP kinase inhibition: in-silico and in-vitro approaches
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have